Literature DB >> 18322091

Acetylcholinesterase expression in muscle is specifically controlled by a promoter-selective enhancesome in the first intron.

Shelley Camp1, Antonella De Jaco, Limin Zhang, Michael Marquez, Brian De la Torre, Palmer Taylor.   

Abstract

Mammalian acetylcholinesterase (AChE) gene expression is exquisitely regulated in target tissues and cells during differentiation. An intron located between the first and second exons governs a approximately 100-fold increase in AChE expression during myoblast to myotube differentiation in C2C12 cells. Regulation is confined to 255 bp of evolutionarily conserved sequence containing functional transcription factor consensus motifs that indirectly interact with the endogenous promoter. To examine control in vivo, this region was deleted by homologous recombination. The knock-out mouse is virtually devoid of AChE activity and its encoding mRNA in skeletal muscle, yet activities in brain and spinal cord innervating skeletal muscle are unaltered. The transcription factors MyoD and myocyte enhancer factor-2 appear to be responsible for muscle regulation. Selective control of AChE expression by this region is also found in hematopoietic lineages. Expression patterns in muscle and CNS neurons establish that virtually all AChE activity at the mammalian neuromuscular junction arises from skeletal muscle rather than from biosynthesis in the motoneuron cell body and axoplasmic transport.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18322091      PMCID: PMC2692871          DOI: 10.1523/JNEUROSCI.4600-07.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  63 in total

Review 1.  Transcriptional enhancers: Intelligent enhanceosomes or flexible billboards?

Authors:  David N Arnosti; Meghana M Kulkarni
Journal:  J Cell Biochem       Date:  2005-04-01       Impact factor: 4.429

Review 2.  The molecular mechanisms that control thrombopoiesis.

Authors:  Kenneth Kaushansky
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

3.  The C-terminal peptides of acetylcholinesterase: cellular trafficking, oligomerization and functional anchoring.

Authors:  Jean Massoulié; Suzanne Bon; Noël Perrier; Cinzia Falasca
Journal:  Chem Biol Interact       Date:  2005-10-28       Impact factor: 5.192

4.  Expression and distribution of acetylcholinesterase among the cellular components of the neuromuscular junction formed in human myotube in vitro.

Authors:  Katarina Mis; Tomaz Mars; Marko Jevsek; Helena Strasek; Marko Golicnik; Janez Brecelj; Rado Komel; Michael P King; Armand F Miranda; Zoran Grubic
Journal:  Chem Biol Interact       Date:  2005-10-26       Impact factor: 5.192

5.  Remodeling of the neuromuscular junction in mice with deleted exons 5 and 6 of acetylcholinesterase.

Authors:  Emmanuelle Girard; Véronique Bernard; Shelley Camp; Palmer Taylor; Eric Krejci; Jordi Molgó
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

6.  Identification of a new hybrid serum response factor and myocyte enhancer factor 2-binding element in MyoD enhancer required for MyoD expression during myogenesis.

Authors:  Aurore L'honore; Vanessa Rana; Nikola Arsic; Celine Franckhauser; Ned J Lamb; Anne Fernandez
Journal:  Mol Biol Cell       Date:  2007-03-21       Impact factor: 4.138

7.  Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.

Authors:  Bin Li; Meghan Sedlacek; Indumathi Manoharan; Rathnam Boopathy; Ellen G Duysen; Patrick Masson; Oksana Lockridge
Journal:  Biochem Pharmacol       Date:  2005-10-06       Impact factor: 5.858

8.  Acetylcholinesterase (AChE) gene modification in transgenic animals: functional consequences of selected exon and regulatory region deletion.

Authors:  Shelley Camp; Limin Zhang; Michael Marquez; Brian de la Torre; Jeffery M Long; Goran Bucht; Palmer Taylor
Journal:  Chem Biol Interact       Date:  2005-11-09       Impact factor: 5.192

9.  Assembly of acetylcholinesterase tetramers by peptidic motifs from the proline-rich membrane anchor, PRiMA: competition between degradation and secretion pathways of heteromeric complexes.

Authors:  Hiba Noureddine; Claudine Schmitt; Wangqing Liu; Christiane Garbay; Jean Massoulié; Suzanne Bon
Journal:  J Biol Chem       Date:  2006-12-08       Impact factor: 5.157

10.  Origin of acetylcholinesterase in the neuromuscular junction formed in the in vitro innervated human muscle.

Authors:  Marko Jevsek; Tomaz Mars; Katarina Mis; Zoran Grubic
Journal:  Eur J Neurosci       Date:  2004-12       Impact factor: 3.386

View more
  13 in total

1.  Naturally occurring variations in the human cholinesterase genes: heritability and association with cardiovascular and metabolic traits.

Authors:  Anne M Valle; Zoran Radic; Brinda K Rana; Vafa Mahboubi; Jennifer Wessel; Pei-an Betty Shih; Fangwen Rao; Daniel T O'Connor; Palmer Taylor
Journal:  J Pharmacol Exp Ther       Date:  2011-04-14       Impact factor: 4.030

2.  Non-synaptic roles of acetylcholinesterase and agrin.

Authors:  Katarina Gros; Giulia Parato; Sergej Pirkmajer; Katarina Mis; Matej Podbregar; Zoran Grubic; Paola Lorenzon; Tomaz Mars
Journal:  J Mol Neurosci       Date:  2013-12-11       Impact factor: 3.444

3.  Distinct localization of collagen Q and PRiMA forms of acetylcholinesterase at the neuromuscular junction.

Authors:  Véronique Bernard; Emmanuelle Girard; Anna Hrabovska; Shelley Camp; Palmer Taylor; Benoit Plaud; Eric Krejci
Journal:  Mol Cell Neurosci       Date:  2010-09-29       Impact factor: 4.314

4.  Contributions of selective knockout studies to understanding cholinesterase disposition and function.

Authors:  Shelley Camp; Limin Zhang; Eric Krejci; Alexandre Dobbertin; Véronique Bernard; Emmanuelle Girard; Ellen G Duysen; Oksana Lockridge; Antonella De Jaco; Palmer Taylor
Journal:  Chem Biol Interact       Date:  2010-02-11       Impact factor: 5.192

5.  Targeting of acetylcholinesterase in neurons in vivo: a dual processing function for the proline-rich membrane anchor subunit and the attachment domain on the catalytic subunit.

Authors:  Alexandre Dobbertin; Anna Hrabovska; Korami Dembele; Shelley Camp; Palmer Taylor; Eric Krejci; Véronique Bernard
Journal:  J Neurosci       Date:  2009-04-08       Impact factor: 6.167

6.  Influence of differential expression of acetylcholinesterase in brain and muscle on respiration.

Authors:  Eliane Boudinot; Véronique Bernard; Shelley Camp; Palmer Taylor; Jean Champagnat; Eric Krejci; Arthur S Foutz
Journal:  Respir Physiol Neurobiol       Date:  2008-10-11       Impact factor: 1.931

7.  From Split to Sibenik: the tortuous pathway in the cholinesterase field.

Authors:  Palmer Taylor
Journal:  Chem Biol Interact       Date:  2010-05-20       Impact factor: 5.192

8.  Sepsis Strengthens Antagonistic Actions of Neostigmine on Rocuronium in a Rat Model of Cecal Ligation and Puncture.

Authors:  Jin Wu; Tian Jin; Hong Wang; Shi-Tong Li
Journal:  Chin Med J (Engl)       Date:  2016-06-20       Impact factor: 2.628

9.  The Long Intron 1 of Growth Hormone Gene from Reeves' Turtle (Chinemys reevesii) Correlates with Negatively Regulated GH Expression in Four Cell Lines.

Authors:  Wen-Sheng Liu; Jing-E Ma; Wei-Xia Li; Jin-Ge Zhang; Juan Wang; Qing-Hua Nie; Feng-Fang Qiu; Mei-Xia Fang; Fang Zeng; Xing Wang; Xi-Ran Lin; Li Zhang; Shao-Hao Chen; Xi-Quan Zhang
Journal:  Int J Mol Sci       Date:  2016-04-12       Impact factor: 5.923

10.  Phenylbutazone induces expression of MBNL1 and suppresses formation of MBNL1-CUG RNA foci in a mouse model of myotonic dystrophy.

Authors:  Guiying Chen; Akio Masuda; Hiroyuki Konishi; Bisei Ohkawara; Mikako Ito; Masanobu Kinoshita; Hiroshi Kiyama; Tohru Matsuura; Kinji Ohno
Journal:  Sci Rep       Date:  2016-04-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.